Artelo Biosciences, Inc. Financial Ratios — ARTLW Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-95.98	-287.99	-81.3	-482.56	-63.15	-85.74	-87.44	-61	-55.51	-110.77	-343.49
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.01	- -	-0.01	-0.06
Net Debt/EBITDA	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.89	0.67	0.28	0.23	- -
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.01	-0.01	- -	-0.01	-0.06
Net Debt/EBIT	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.89	0.67	0.28	0.23	- -
EBITDA to Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -	- -	-41.17
EBITDA-CapEx/Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -	- -	-41.17
EBIT to Interest Expense	- -	- -	- -	-110.85	- -	- -	- -	- -	-2,057.4	- -	- -	-41.17
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-62.92	-134.3	-1,464.07	-49.41	-664.19	-74.16	-216.2	-133.76	-151.87	-309.03	-1,067.16	-2,249.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.56	0.12	- -	2.42	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.4	-0.07	- -	-0.14	-0.05
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.11	- -	1.47	1.04
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.79	0.32	0.2	3.64	-53.3
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06	-0.21	-1.09
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.75	0.31	0.18	2.21	24.21
Net Debt to Equity	-100	-111.37	26.01	-105.13	249.99	-81.01	-55.28	-55.05	-35.5	-23.95	-81.83	-0.71
Net Debt/Capital (%)	61.38	42.68	6.39	66.87	11.34	47.92	18.46	28.29	18.2	6.53	4.46	-0.01
EBITDA	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10	-10	-11
EBITDA-CapEx	- -	- -	- -	- -	-2	-5	-5	-7	-10	-10	-10	-11
Operating Income (Loss)	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10	-10	-11

Liquidity (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	9.79	0.21	19.46	0.63	4.33	4.28	19.13	17.57	8.08	1.32	0.15
Current Ratio	- -	9.79	0.21	19.51	0.75	4.35	4.66	19.61	18.36	8.51	1.44	0.17
Quick Ratio	- -	9.79	0.21	19.46	0.68	4.34	4.28	19.13	17.57	8.08	1.32	0.15
CFO/Avg Current Liab	- -	-15.53	-1.93	-9.26	-5.74	-3.6	-5.71	-11.96	-10.51	-7.17	-5.45	-2.93
Common Equity/Total Assets	-62.92	-134.3	-1,464.07	-49.41	-664.19	-74.16	-216.2	-133.76	-151.87	-309.03	-1,067.16	-2,249.66
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.56	0.12	- -	2.42	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.4	-0.07	- -	-0.14	-0.05
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.11	- -	1.47	1.04
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	0.79	0.32	0.2	3.64	-53.3
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06	-0.21	-1.09
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.75	0.31	0.18	2.21	24.21
CFO/Total Liabilities	- -	-776.42	-106.32	-736.53	-302.65	-273.39	-867.66	-1,035.58	-784.33	-635.71	-453.56	-209.18
CFO/CapEx	- -	- -	- -	- -	-1,905.35	-1.86	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	-4.38	-55.38	-0.92	-29.19	-2.98	-11.34	-3.44	-3.08	-7.05	-38.59	-170.44

Working Capital (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	1	- -	4	2	7	7	3	2	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Enterprise Value	- -	- -	- -	-1	- -	-4	-2	-10	-17	-10	-2	- -
Total Capital	- -	- -	- -	- -	-3	-5	-9	-17	-31	-40	-50	-62
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.57	-0.2	-0.06	-0.21	-1.09
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	-0.01	- -	- -	-0.05	8.69
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	-1	- -	-4	-2	-7	-7	-3	-2	- -
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10	-10	-11
TTM Operating Income	- -	- -	- -	- -	-2	-3	-5	-7	-10	-10	-10	-11
TTM Cash Flow to Firm	- -	- -	- -	- -	-2	-3	-4	-6	-8	-8	-8	-8
TTM Free Cash Flow to Firm	- -	- -	- -	- -	-2	-1	-4	-6	-8	-8	-8	-8

Multiples (USD)

API Chat

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	-1	- -	-4	-2	-10	-17	-10	-2	- -
Low Price	- -	- -	- -	- -	- -	0.5	0.04	0.04	0.03	- -	0.01	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
EV/EBITDA High	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
EV/EBITDA Low	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
EV/EBIT Average	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
EV/EBIT High	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
EV/EBIT Low	0.96	1.12	0.12	2.46	0.14	1.38	0.46	0.88	0.66	0.28	0.22	-0.01
Last Price	- -	- -	- -	- -	- -	0.57	0.1	0.29	0.04	0.04	0.01	- -
High Price	- -	- -	- -	- -	- -	1.25	0.67	0.92	0.42	0.21	0.1	- -
Enterprise Value Average	- -	- -	- -	-1	- -	-4	-2	-7	-7	-3	-2	- -
Enterprise Value High	- -	- -	- -	-1	- -	-4	-2	-7	-7	-3	-2	- -
Enterprise Value Low	- -	- -	- -	-1	- -	-4	-2	-7	-7	-3	-2	- -

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Artelo Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)